
sclerotherapy using standardized polidocanol foam. The
3% foam was more efficient than and equally as safe as the
3% liquid for the treatment of the incompetent GSV.
In a prospective comparative study, Yamaki et al332
compared results of duplex-guided foam sclerotherapy and
duplex-guided liquid sclerotherapy in 77 patients. Duplex
scanning at 1 year demonstrated complete occlusion in the
GSV